LIQUIFIX FIX8 Laparoscopic Hernia Mesh Fixation (HMF) Device; LIQUIFIX Precision Open Hernia Mesh Fixation Device
Advanced Medical Solutions Limited · Decision date Oct 23, 2026
What did the FDA approve?
The FDA record for P220024/S007 describes a normal 180-day-track supplement without user fee, filed under the postapproval study protocol reason for Advanced Medical Solutions Limited's LIQUIFIX FIX8 laparoscopic hernia mesh fixation device and LIQUIFIX Precision open hernia mesh fixation device. According to the source statement, the approval covers a revised LIQUFIX Post-Approval Study protocol intended to address patient enrollment issues by combining the laparoscopic and open devices into a single body of evidence and revising patient sample sizes for both devices.
The identifier ties this action to the original PMA P220024; the statement says the PAS protocol was submitted to comply with conditions of approval in that approval order. This supplement is not a new approval of the whole system, and the stated purpose of the protocol change is not independent proof of safety or clinical effectiveness. The supplied fields do not specify the revised sample sizes, enrollment targets, endpoints, or timelines.
FDA approval order statement
approval of the revised protocol to address patient enrollment issues associated with the LIQUFIX Post-Approval Study (PAS). The changes are, namely, the combining the laparoscopic and open devices into a single body of evidence and to revising the patient sample sizes for both devices. The PAS protocol has been submitted to comply with the conditions of approval outlined in our approval order for P220024.
- Regulatory pathway
- PMA supplement
- Supplement type
- Normal 180 Day Track No User Fee
- Clinical specialty
- General, Plastic Surgery
- Decision date
- Oct 23, 2026
- FDA change category
- Postapproval Study Protocol
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P220024/S007
- Regulatory pathway
- PMA supplement
- Applicant
- Advanced Medical Solutions Limited
- Product code
- PLJ
- Decision code
- APPR
- Decision date
- Oct 23, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Tissue adhesive internal use.
- Applicant
- Advanced Medical Solutions Limited
- Product code
- PLJ
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P220024. Subsequent supplements may change the device or its indications.
FDA decision timeline
P220024 · Original PMA
LIQUIFIX FIX8 Hernia Mesh Fixation (HMF) Device, LIQUIFIX Precision Open Hernia Mesh Fixation Device
P220024/S007 received
Application receipt date recorded by FDA.
P220024/S007 · FDA decision
Normal 180 Day Track No User Fee
Timeline entries are records held by MedtechLedger for P220024. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P220024
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Advanced Medical Solutions Limited | PMA approval | Jun 2, 2023 | FDA |
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Advanced Medical Solutions Limited
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Western Wood Way, Langage Science Park, Plymouth, PL7 5BG
Sources and methodology
- Original FDA record: P220024/S007
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records